ILLUMINA, INC. — Director's Dealing 2013

Nov 25, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ILLUMINA INC (ILMN)
CIK: 0001110803
Period of Report: 2013-11-21

Reporting Person: HENRY CHRISTIAN O (Sr VP, General Manager Genomic)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-21	Common Stock	M	6000.0	$28.45	Acquired	36236	Direct
2013-11-21	Common Stock	S	1200.0	$93.4571	Disposed	35036	Direct
2013-11-21	Common Stock	S	3200.0	$94.5479	Disposed	31836	Direct
2013-11-21	Common Stock	S	1300.0	$95.6718	Disposed	30536	Direct
2013-11-21	Common Stock	S	300.0	$96.3775	Disposed	30236	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-21	Non-Qualified Stock Option (right to buy)	$28.45	M	6000.0	Disposed	2019-01-28	Common Stock (6000)	Direct

Footnotes

F1: The sale was made pursuant to a 10b5-1 plan.

F2: Weighted average sales price representing 1,200 shares sold ranging from $92.85 to $93.78 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F3: Weighted average sales price representing 3,200 shares sold ranging from $94.05 to $95.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F4: Weighted average sales price representing 1,300 shares sold ranging from $95.34 to $96.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.